Martinez-Vea A, Gatell J M, Segura F, Heiman C, Elena M, Ballesta A M, Mundo M R
Cancer. 1982 Nov 1;50(9):1783-8. doi: 10.1002/1097-0142(19821101)50:9<1783::aid-cncr2820500923>3.0.co;2-v.
In order to discriminate between benign and malignant effusions, the value of carcinoembryonic antigen (CEA), alpha 1-acidglycoprotein (AGP), alpha-fetoprotein (AFP), phosphohexose isomerase (PHI), and beta 2-microglobulin (B2M) has been estimated in serous effusions in a group of 106 patients, 30 with a malignant and 76 with a benign effusion. Mean CEA and AGP levels in malignant effusions were significantly higher than in benign effusions; no significant differences of mean PHI, AFP and B2M levels of benign and malignant effusions were found. CEA level estimations were useful for confirming malignancy in 27% of malignant effusions but in only 7.5% of all effusions, and AGP and PHI for excluding it in 37.5 and 36.0% of all effusions, respectively. With the combination of CEA with AGP or PHI, a correct diagnosis was achieved in only 45 and 44% of all effusions, respectively. The combination of AFP or B2M with CEA, AGP or PHI did not improve the discriminative value for differentiating malignant and benign effusions.
为了鉴别良性和恶性积液,对106例患者的浆液性积液中的癌胚抗原(CEA)、α1-酸性糖蛋白(AGP)、甲胎蛋白(AFP)、磷酸己糖异构酶(PHI)和β2-微球蛋白(B2M)的值进行了评估,其中30例为恶性积液,76例为良性积液。恶性积液中的平均CEA和AGP水平显著高于良性积液;未发现良性和恶性积液的平均PHI、AFP和B2M水平有显著差异。CEA水平测定对27%的恶性积液确诊恶性肿瘤有用,但仅对7.5%的所有积液有用,AGP和PHI分别对37.5%和36.0%的所有积液排除恶性肿瘤有用。CEA与AGP或PHI联合使用时,分别仅对45%和44%的所有积液做出了正确诊断。AFP或B2M与CEA、AGP或PHI联合使用并未提高鉴别恶性和良性积液的判别价值。